A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia

Clinical trial NCT03873493 · COMPLETED

Trial details

NCT number: NCT03873493
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia T-cell Prolymphocytic Leukemia (T-PLL)Cancer

Start date: 2020-01-14
Primary completion: 2021-11-04
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.